CRDL News
Cardiol Therapeutics Announces At-The-Market Equity Offering Program With Jefferies LLC
Cardiol Therapeutics Announces At-The-Market Equity Offering Program With Jefferies LLC Cardiol Therapeutics Announces At-The-Market Equity Offering Program With Jefferies LLCPR NewswireTORONTO, Nov. 3, 2026 TORONTO, Nov. 3, 2026 /PRNewswire/ -- Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL...
PR Newswire
Cardiol Therapeutics Announces At-The-Market Equity Offering Program With Jefferies LLC
Cardiol Therapeutics Announces At-The-Market Equity Offering Program With Jefferies LLC Cardiol Therapeutics Announces At-The-Market Equity Offering Program With Jefferies LLCPR NewswireTORONTO, Nov. 3, 2026 TORONTO, Nov. 3, 2026 /PRNewswire/ -- Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL...
PR Newswire
Cardiol Therapeutics Achieves Phase III MAVERIC Enrollment Target Ahead of Schedule and Expands Pivotal Trial to Strengthen Assessment of CardiolRx's Efficacy
Cardiol Therapeutics Achieves Phase III MAVERIC Enrollment Target Ahead of Schedule and Expands Pivotal Trial to Strengthen Assessment of CardiolRx's Efficacy Cardiol Therapeutics Achieves Phase III MAVERIC Enrollment Target Ahead of Schedule and Expands Pivotal Trial to Strengthen Assessment of...
PR Newswire
Cardiol Therapeutics Announces Warrant Exercise for Over USD $7 Million in Proceeds
Cardiol Therapeutics Announces Warrant Exercise for Over USD $7 Million in Proceeds Cardiol Therapeutics Announces Warrant Exercise for Over USD $7 Million in ProceedsPR NewswireTORONTO, Sept. 16, 2026 Proceeds strengthen balance sheet ahead of pivotal Phase III MAVERIC trial data readout in...
PR Newswire
5 Small Drug Stocks Poised to Benefit From a Biotech Recovery
INDV, IRWD, RLMD, LRMR and CRDL could offer significant upside as biotech sentiment improves, backed by catalysts and differentiated pipelines.
Zacks
Cardiol Therapeutics Files US$150 Million Preliminary Base Shelf Prospectus Including Additional Disclosure Following Review by Staff of the Ontario Securities Commission
Cardiol Therapeutics Files US$150 Million Preliminary Base Shelf Prospectus Including Additional Disclosure Following Review by Staff of the Ontario Securities Commission Cardiol Therapeutics Files US$150 Million Preliminary Base Shelf Prospectus Including Additional Disclosure Following Review by...
PR Newswire
Is Aspen Pharmacare (APNHY) Outperforming Other Medical Stocks This Year?
Here is how Aspen Pharmacare (APNHY) and Cardiol Therapeutics Inc. (CRDL) have performed compared to their sector so far this year.
Zacks
Cardiol Therapeutics to Participate in a Fireside Chat at the H.C. Wainwright 28th Annual Global Investment Conference
Cardiol Therapeutics to Participate in a Fireside Chat at the H.C. Wainwright 28th Annual Global Investment Conference Cardiol Therapeutics to Participate in a Fireside Chat at the H.C. Wainwright 28th Annual Global Investment Conference PR Newswire TORONTO, Sept. 9, 2026 TORONTO, Sept. 9, 2026...
PR Newswire
Is Cardiol Therapeutics (CRDL) Stock Outpacing Its Medical Peers This Year?
Here is how Cardiol Therapeutics Inc. (CRDL) and Charles River Laboratories (CRL) have performed compared to their sector so far this year.
Zacks
Cardiol Therapeutics Inc. (CRDL) is a Great Momentum Stock: Should You Buy?
Does Cardiol Therapeutics Inc. (CRDL) have what it takes to be a top stock pick for momentum investors? Let's find out.
Zacks
Cardiol Therapeutics to Participate in Fireside Chat at Canaccord Genuity's 46th Annual Growth Conference
Cardiol Therapeutics to Participate in Fireside Chat at Canaccord Genuity's 46th Annual Growth Conference Cardiol Therapeutics to Participate in Fireside Chat at Canaccord Genuity's 46th Annual Growth Conference PR Newswire TORONTO, Aug. 5, 2026 TORONTO, Aug. 5, 2026 /PRNewswire/ -- Cardiol...
PR Newswire